Healthy Patients

Antimicrobial resistance (AMR)

AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.

AMR Insights

For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.

AMR Insights is for:

  • Medical Microbiologists, Infectiologists and other specialists
  • General Practitioners, Pharmacists
  • Infection Prevention Experts and nurses
  • Medical Docters and Caretakers in nursing homes
  • Managers and Labtechnicians of Microbiological Laboratories.

Latest Topics

  •   21 March 2025

    Exploring the role of gut microbiota in antibiotic resistance and prevention

    Antibiotic resistance (AMR) is a significant public health concern, and novel drug development strategies are needed to combat the pandemic. The gut microbiome plays a crucial role in determining pathogenesis, and understanding microbial diversity and its role in adapting pathogens to AMR is essential. Strategies to prevent or treat dysbiosis include faecal microbiota transplantation, probiotics, […]

    Read more...
  •   20 March 2025

    AMR-detecting wound sensors: sensor arrays to diagnose beta-lactamase activity in a wound

    Anti-microbial resistance (AMR) is a significant threat to humanity, particularly in chronic wounds that can become colonized with bacteria, leading to wound infection. β-lactam antibiotics are key treatments, but β-lactamases, antibiotic-inactivating enzymes, are the leading cause of AMR. A project aims to use electrochemical sensors to measure β-lactamase enzymes in wound models, allowing for point-of-care […]

    Read more...
  •   17 March 2025

    Roadmap for Establishing an Independent Panel for Evidence for Action against Antimicrobial Resistance (IPEA)

    Summary of the IPEA Roadmap (10 Lines) Objective: Establish the Independent Panel for Evidence for Action against AMR (IPEA) in 2025, following the 79th UNGA Political Declaration. Background: AMR threatens global health, food security, and economies, requiring coordinated, science-driven responses. Need for IPEA: Policymakers need robust, interdisciplinary scientific evidence; IPEA will fill gaps and guide […]

    Read more...

More news related to Healthy patients

Please call me back

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!